Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.5600 (-2.1%) ($18.9500 - $20.3300) on Sat. Apr. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.76% (three month average) | RSI | 71 | Latest Price | $19.5600(-2.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -2.88% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.88% (StdDev 5.76%) | Hourly BBV | 0 () | Intraday Trend | -3% | | | |
|
5 Day Moving Average | $19.62(-0.31%) | 10 Day Moving Average | $20.09(-2.64%) | 20 Day Moving Average | $19.54(0.1%) | To recent high | -40.3% | To recent low | 31.5% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |